Secondary prevention measures after a stroke - Should they target stroke or heart disease? Commentary

Nature Clinical Practice Neurology

Volumn 2, Issue 12, 2006, Pages 646-647

  Fayad, Pierre ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPYRIDAMOLE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTERY DISEASE; BLEEDING; BRAIN ISCHEMIA; CAUSE OF DEATH; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DRUG TARGETING; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART INFARCTION; HUMAN; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SECONDARY PREVENTION; SHORT SURVEY; STROKE; TREATMENT PLANNING;

EID: 33751205062     PISSN: 1745834X     EISSN: 17458358     Source Type: Journal    
DOI: 10.1038/ncpneuro0352     Document Type: Short Survey

References (5)

1. Dahlof B et al. (2002) Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet 359: 995-1003
2. Amarenco P et al. (2006) High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355: 549-559
3. Yusuf S et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. The Clopidogrel in Unstable Angina To Prevent Recurrent Events (CURE) Trial Investigators. N Engl J Med 345: 494-502
4. Bhatt DL et al. (2006) Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354: 1706-1717
5. Halkes PH et al. (2006) Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): Randomised controlled trial. Lancet 367: 1665-1673